Guardant Health, Inc. v. Foundation Medicine, Inc.
Patentability filed 26 Oct 2020 in the United States Court of Appeals for the Federal Circuit and closed 5 May 2023, with US9834822B2 asserted. Recorded basis of termination: vacated and remanded.
Case record
- Patent involved
- US9834822B2
- Application no.
- US15/492659
- Case no.
- 21-1104
- Verdict cause
- Patentability
- Court
- Fed. Cir.
- Court level
- Court of Appeals
- Case region
- District of Columbia
- Chief judge
- None recorded
- Trial level
- Appeal
- Filed – Closed
- 26 Oct 2020 – 5 May 2023
- Duration
- 921 days
- Basis of termination
- Vacated and Remanded
- Products & marks
- Systems and methods to detect rare mutations and copy number variation
- Validity challenges
- 4 on record
Check this patent against your own product
Prior art, claim scope, infringement exposure and design-around routes. Every answer cites the records behind it.
Get an FTO claim chart- 01Ranked prior artEvery hit source-linked
- 02Claim-level comparisonAgainst your own product
- 03Legal statusAcross 174 jurisdictions
Systems and methods to detect rare mutations and copy number variation
The present disclosure provides a system and method for the detection of rare mutations and copy number variations in cell free polynucleotides. Generally, the systems and methods comprise sample preparation, or the extraction and isolation of cell free polynucleotide sequences from a bodily fluid; subsequent sequencing of cell free polynucleotides by techniques known in the art; and application of bioinformatics tools to detect rare mutations and copy number variations as compared to a reference. The systems and methods also may contain a database or collection of different rare mutations or copy number variation profiles of different diseases, to be used as additional references in aiding detection of rare mutations, copy number variation profiling or general genetic profiling of a disease.
- Legal status
- Active
- Granted
- 5 Dec 2017
- Earliest priority
- 4 Sep 2013
- Est. expiry
- 4 Sep 2033
- Validity challenges
- 4 on recordIPR2019-00652 · Patentability · filed by Foundation Medicine, Inc.PGR2018-00058 · filed by Personal Genome Diagnostics, Inc.IPR2019-00652 · filed by Foundation Medicine, Inc.IPR2019-00653 · filed by Foundation Medicine, Inc.
- Licences recorded
- None recorded
- Inventors
- TALASAZ, AMIRALI
- Classification
- C12P19/34C12Q1/68G06F19/22G16B30/10
- Prosecution counsel
- WSGR
- Examiner
- HORLICK, KENNETH
Parties of record
Guardant Health, Inc.
- Core tech
- C12P19/34C12Q1/68G06F19/22G16B30/10
- Counsel
- Michael T. Rosato · Richard Torczon · Sonja Rochelle Gerrard Ph.D.
- Firm
- WilsonSonsini Goodrich & Rosati LLP
Foundation Medicine, Inc.
- Core tech
- Not recorded
- Counsel
- Not recorded
- Firm
- Not recorded
Counsel of record
| Attorney | For | Role |
|---|---|---|
| Michael T. Rosato | Guardant Health, Inc. | Plaintiff |
| Richard Torczon | Guardant Health, Inc. | Plaintiff |
| Sonja Rochelle Gerrard Ph.D. | Guardant Health, Inc. | Plaintiff |
Basis of termination
From the record · verbatim“THIS CAUSE having been considered, it is ORDERED AND ADJUDGED: VACATED AND REMANDED”
Case 21-1104 · Fed. Cir. · closed 5 May 2023
Related cases
Three questions this record usually leads to. Each one runs against the full litigation and patent corpus, and cites what it finds.
Frequently asked questions
What is case 21-1104?
21-1104 is a patent patentability brought by Guardant Health, Inc. against Foundation Medicine, Inc., filed on 26 Oct 2020 in the United States Court of Appeals for the Federal Circuit. The case closed on 5 May 2023.
Which patent was asserted in 21-1104?
US9834822B2 (“Systems and methods to detect rare mutations and copy number variation”), assigned to GUARDANT HEALTH, INC., currently active. The record also lists Systems and methods to detect rare mutations and copy number variation.
How was case 21-1104 terminated?
The recorded basis of termination is vacated and remanded. The termination text reads: “THIS CAUSE having been considered, it is ORDERED AND ADJUDGED: VACATED AND REMANDED”
How long did case 21-1104 take?
921 calendar days, from filing on 26 Oct 2020 to closure on 5 May 2023.
Who were the attorneys and the judge in 21-1104?
Michael T. Rosato, Richard Torczon and Sonja Rochelle Gerrard Ph.D. are recorded as counsel for plaintiff Guardant Health.
Disclaimer. This page reproduces publicly available court docket data for case 21-1104 and is provided for general information and reference only. It is not legal advice and must not be relied upon as such.
Docket data has limits. Records are drawn from a snapshot and may lag the live docket. Sealed filings, amended complaints, counterclaims and post-closure motions may not be reflected. Party names, attorney names and firm affiliations are reproduced as recorded and may contain omissions. Where a field is absent from the record, this page marks it as not recorded rather than inferring a value.
No characterisation of the parties or the outcome. This page reports what the record contains. Nothing here should be read as an assertion that any party infringed, that any patent is valid or invalid, that any settlement occurred, or that any party prevailed.
No FTO or validity opinion. Nothing on this page constitutes a freedom-to-operate, novelty, validity or infringement opinion. Any decision touching a live patent dispute should be verified independently and reviewed with qualified patent counsel.